Calendar Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq 16:00:00 2024-06-17 EDT 5-day change 1st Jan Change
32.47 USD -2.76% Intraday chart for Protagonist Therapeutics, Inc. -2.11% +41.60%

Chart calendar Protagonist Therapeutics, Inc.

f7a2.4_5qy4G5RFCWheO6YdKvNVk1JlDef3jOVa__ZDBtJUQ.qMoeh9TOMCfY9af9G4eabQhddTesMTCJGd-tEVIpchWpsFi-6-MVNq6ojA~0a0d2a099f4f66833f213d8189a25479

Upcoming events on Protagonist Therapeutics, Inc.

2024-06-20 13:00 Annual General Meeting
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-17 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Protagonist Therapeutics, Inc.

2024-06-14 08:45 European Hematology Association Meeting
2024-06-05 11:00 Jefferies Global Healthcare Conference
2024-05-14 14:45 Capital One Biotech/Biopharma Disruptors Conference - Panel
2024-05-13 14:00 Citizens JMP Life Sciences Conference - Fireside Chat
2024-05-08 16:05 Q1 2024 Earnings Release
2024-03-28 13:00 H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
2024-03-26 13:30 Napa Valley Biotech Forum
2024-03-11 Jefferies Biotech on the Bay Summit
2024-03-10 American Academy of Dermatology Meeting
2024-02-27 16:05 Q4 2023 Earnings Release
2024-02-08 09:00 Guggenheim Healthcare Talks Biotechnology Conference
2024-01-31 16:30 Business Update Call
2024-01-09 12:45 JPMorgan Healthcare Conference
2023-12-11 13:30 American Society of Hematology Meeting - Session Name: 634
2023-12-10 21:00 American Society of Hematology Meeting - Session Name: 634
2023-12-09 20:30 American Society of Hematology Meeting - Session Name: 113
2023-12-09 13:30 American Society of Hematology Meeting - Session Name: 904
2023-11-14 04:00 Jefferies London Healthcare Conference - Fireside Chat
2023-11-09 14:25 Truist Securities Healthcare Conference - Panel
2023-11-06 J.P. Morgan Equity Opportunities Forum

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,23
1,74
-86.69%
28,6
25,7
11.45%
27,4
23,2
17.93%
26,6
31,4
-15.46%
60,0
30,0
100%

292

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-63,7
-68,7
7.22%
-125
-135
7.38%
0,00
0,00
-
-92,7
-96,0
3.46%

212

EBIT
Million USD
Released
Forecast
Spread
-80,5
-81,8
1.55%
-64,5
-65,4
1.29%
-126
-128
1.54%
-131
-125
-5.35%
-93,7
-127
26.5%

102

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-77,9
-79,3
1.83%
-64,8
-64,1
-1.11%
-126
-128
2.06%
-127
-127
-0.41%
-79,0
-116
31.76%

139

Net income
Million USD
Released
Forecast
Spread
-77,2
-77,9
0.89%
-66,2
-66,2
0.04%
-126
-128
1.93%
-127
-123
-3.53%
-79,0
-115
31.24%

103

EPS
USD
Released
Forecast
Spread
-2,98
-3,00
0.6%
-1,92
-1,94
0.84%
-2,71
-2,73
0.78%
-2,60
-2,49
-4.44%
-1,39
-2,02
31.28%

1,52

Announcement Date10/03/2010/03/2128/02/2215/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
25,7
17,1
50.86%
0,86
0,38
124.09%
0,00
0,00
-
0,00
5,00
-
0,00
1,67
-
0,00
0,00
-
0,00
0,00
-
60,0
30,0
100%
255
120
112.46%

6,67


0,83


29,2


0,00


100

EBITDA
Million USD
Released
Forecast
Spread
-20,9
-50,0
58.28%
-41,2
-52,0
20.8%
-32,0
-43,0
25.5%
-36,3
-33,0
-9.88%
-35,8
-37,0
3.32%
-42,1
-37,0
-13.83%
-38,1
-43,0
11.44%
23,3
21,0
10.94%
207
-38,0
643.54%

-44,0


-45,0


94,0







EBIT
Million USD
Released
Forecast
Spread
-21,1
-27,8
24.07%
-41,4
-46,3
10.55%
-32,3
-43,3
25.35%
-36,5
-29,0
-25.97%
-36,0
-36,3
0.65%
-42,4
-36,5
-15.94%
-38,3
-42,6
9.96%
23,0
-10,1
328.49%
206
36,9
458.72%

-39,8


-46,1


-18,6







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,9
-31,6
33.77%
-41,0
-48,9
16.01%
-31,2
-41,7
25.09%
-34,2
-33,6
-1.71%
-33,7
-33,5
-0.69%
-38,5
-35,0
-9.97%
-34,1
-39,7
14.11%
27,3
-8,04
440.04%
211
114
84.39%

-42,9


-43,3


14,2







Net income
Million USD
Released
Forecast
Spread
-20,9
-30,4
31.15%
-41,0
-45,9
10.65%
-31,2
-43,0
27.39%
-34,2
-29,4
-16.27%
-33,7
-35,9
6.05%
-38,5
-35,5
-8.2%
-34,1
-40,2
15.17%
27,3
-7,61
459.24%
207
39,3
427.28%

-44,8


-45,0


-11,0







EPS
USD
Released
Forecast
Spread
-0,43
-0,63
31.57%
-0,84
-0,94
10.17%
-0,64
-0,87
26.31%
-0,69
-0,59
-16.49%
-0,67
-0,73
7.78%
-0,68
-0,65
-5.22%
-0,58
-0,69
16.27%
0,44
-0,14
406.9%
3,26
1,19
173.04%

-0,73


-0,73


-0,22


-0,77


0,62

Announcement Date04/05/2204/08/2208/11/2215/03/2304/05/2303/08/2302/11/2327/02/2407/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Calendar Protagonist Therapeutics, Inc.